Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Pancreatic α-cell specific deletion of mouse Arx leads to α-cell identity loss.

PloS one | 2013

The specification and differentiation of pancreatic endocrine cell populations (α-, β-, δ, PP- and ε-cells) is orchestrated by a combination of transcriptional regulators. In the pancreas, Aristaless-related homeobox gene (Arx) is expressed first in the endocrine progenitors and then restricted to glucagon-producing α-cells. While the functional requirement of Arx in early α-cell specification has been investigated, its role in maintaining α-cell identity has yet to be explored. To study this later role of Arx, we have generated mice in which the Arx gene has been ablated specifically in glucagon-producing α-cells. Lineage-tracing studies and immunostaining analysis for endocrine hormones demonstrate that ablation of Arx in neonatal α-cells results in an α-to-β-like conversion through an intermediate bihormonal state. Furthermore, these Arx-deficient converted cells express β-cell markers including Pdx1, MafA, and Glut2. Surprisingly, short-term ablation of Arx in adult mice does not result in a similar α-to-β-like conversion. Taken together, these findings reveal a potential temporal requirement for Arx in maintaining α-cell identity.

Pubmed ID: 23785486 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NICHD NIH HHS, United States
    Id: 5K12HD043245
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK050306
  • Agency: NIDDK NIH HHS, United States
    Id: P30-DK19525
  • Agency: NIDDK NIH HHS, United States
    Id: R56 DK078606
  • Agency: NIDDK NIH HHS, United States
    Id: T32-DK007066
  • Agency: NICHD NIH HHS, United States
    Id: K12 HD043245
  • Agency: NIDDK NIH HHS, United States
    Id: DK019525
  • Agency: NIDDK NIH HHS, United States
    Id: P30-DK050306
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK007066
  • Agency: NIDDK NIH HHS, United States
    Id: DK078606
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK078606
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK019525

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.